IBDEI31Q ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,48639,1,4,0)
;;=4^I69.931
;;^UTILITY(U,$J,358.3,48639,2)
;;=^5007558
;;^UTILITY(U,$J,358.3,48640,0)
;;=I69.933^^185^2424^37
;;^UTILITY(U,$J,358.3,48640,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48640,1,3,0)
;;=3^Cerebrovascular Disease,Monoplegia,Rt Upper Nondominant Side
;;^UTILITY(U,$J,358.3,48640,1,4,0)
;;=4^I69.933
;;^UTILITY(U,$J,358.3,48640,2)
;;=^5007559
;;^UTILITY(U,$J,358.3,48641,0)
;;=I69.998^^185^2424^44
;;^UTILITY(U,$J,358.3,48641,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48641,1,3,0)
;;=3^Cerebrovascular Disease,Sequelae,Unspec
;;^UTILITY(U,$J,358.3,48641,1,4,0)
;;=4^I69.998
;;^UTILITY(U,$J,358.3,48641,2)
;;=^5007572
;;^UTILITY(U,$J,358.3,48642,0)
;;=I69.928^^185^2424^45
;;^UTILITY(U,$J,358.3,48642,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48642,1,3,0)
;;=3^Cerebrovascular Disease,Speech/Language Deficits,Unspec
;;^UTILITY(U,$J,358.3,48642,1,4,0)
;;=4^I69.928
;;^UTILITY(U,$J,358.3,48642,2)
;;=^5007557
;;^UTILITY(U,$J,358.3,48643,0)
;;=I69.965^^185^2424^39
;;^UTILITY(U,$J,358.3,48643,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48643,1,3,0)
;;=3^Cerebrovascular Disease,Paralytic Syndrome,Bilateral,Unspec
;;^UTILITY(U,$J,358.3,48643,1,4,0)
;;=4^I69.965
;;^UTILITY(U,$J,358.3,48643,2)
;;=^5007566
;;^UTILITY(U,$J,358.3,48644,0)
;;=I69.962^^185^2424^40
;;^UTILITY(U,$J,358.3,48644,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48644,1,3,0)
;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Dominant Side
;;^UTILITY(U,$J,358.3,48644,1,4,0)
;;=4^I69.962
;;^UTILITY(U,$J,358.3,48644,2)
;;=^5133588
;;^UTILITY(U,$J,358.3,48645,0)
;;=I69.964^^185^2424^41
;;^UTILITY(U,$J,358.3,48645,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48645,1,3,0)
;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Nondominant Side
;;^UTILITY(U,$J,358.3,48645,1,4,0)
;;=4^I69.964
;;^UTILITY(U,$J,358.3,48645,2)
;;=^5133589
;;^UTILITY(U,$J,358.3,48646,0)
;;=I69.961^^185^2424^42
;;^UTILITY(U,$J,358.3,48646,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48646,1,3,0)
;;=3^Cerebrovascular Disease,Paralytic Syndrome,Rt Dominant Side
;;^UTILITY(U,$J,358.3,48646,1,4,0)
;;=4^I69.961
;;^UTILITY(U,$J,358.3,48646,2)
;;=^5007564
;;^UTILITY(U,$J,358.3,48647,0)
;;=I69.963^^185^2424^43
;;^UTILITY(U,$J,358.3,48647,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48647,1,3,0)
;;=3^Cerebrovascular Disease,Paralytic Syndrome,Rt Nondominant Side
;;^UTILITY(U,$J,358.3,48647,1,4,0)
;;=4^I69.963
;;^UTILITY(U,$J,358.3,48647,2)
;;=^5007565
;;^UTILITY(U,$J,358.3,48648,0)
;;=G90.50^^185^2424^52
;;^UTILITY(U,$J,358.3,48648,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48648,1,3,0)
;;=3^Complex Regional Pain Syndrome I,Unspec
;;^UTILITY(U,$J,358.3,48648,1,4,0)
;;=4^G90.50
;;^UTILITY(U,$J,358.3,48648,2)
;;=^5004163
;;^UTILITY(U,$J,358.3,48649,0)
;;=R56.9^^185^2424^53
;;^UTILITY(U,$J,358.3,48649,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48649,1,3,0)
;;=3^Convulsions,Unspec
;;^UTILITY(U,$J,358.3,48649,1,4,0)
;;=4^R56.9
;;^UTILITY(U,$J,358.3,48649,2)
;;=^5019524
;;^UTILITY(U,$J,358.3,48650,0)
;;=G37.9^^185^2424^54
;;^UTILITY(U,$J,358.3,48650,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48650,1,3,0)
;;=3^Demyelinating Disease of Central Nervous System,Unspec
;;^UTILITY(U,$J,358.3,48650,1,4,0)
;;=4^G37.9
;;^UTILITY(U,$J,358.3,48650,2)
;;=^5003828
;;^UTILITY(U,$J,358.3,48651,0)
;;=G36.9^^185^2424^55
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI31Q 3795 printed Oct 16, 2024@18:40:52 Page 2
IBDEI31Q ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,48639,1,4,0)
+2 ;;=4^I69.931
+3 ;;^UTILITY(U,$J,358.3,48639,2)
+4 ;;=^5007558
+5 ;;^UTILITY(U,$J,358.3,48640,0)
+6 ;;=I69.933^^185^2424^37
+7 ;;^UTILITY(U,$J,358.3,48640,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,48640,1,3,0)
+10 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Upper Nondominant Side
+11 ;;^UTILITY(U,$J,358.3,48640,1,4,0)
+12 ;;=4^I69.933
+13 ;;^UTILITY(U,$J,358.3,48640,2)
+14 ;;=^5007559
+15 ;;^UTILITY(U,$J,358.3,48641,0)
+16 ;;=I69.998^^185^2424^44
+17 ;;^UTILITY(U,$J,358.3,48641,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,48641,1,3,0)
+20 ;;=3^Cerebrovascular Disease,Sequelae,Unspec
+21 ;;^UTILITY(U,$J,358.3,48641,1,4,0)
+22 ;;=4^I69.998
+23 ;;^UTILITY(U,$J,358.3,48641,2)
+24 ;;=^5007572
+25 ;;^UTILITY(U,$J,358.3,48642,0)
+26 ;;=I69.928^^185^2424^45
+27 ;;^UTILITY(U,$J,358.3,48642,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,48642,1,3,0)
+30 ;;=3^Cerebrovascular Disease,Speech/Language Deficits,Unspec
+31 ;;^UTILITY(U,$J,358.3,48642,1,4,0)
+32 ;;=4^I69.928
+33 ;;^UTILITY(U,$J,358.3,48642,2)
+34 ;;=^5007557
+35 ;;^UTILITY(U,$J,358.3,48643,0)
+36 ;;=I69.965^^185^2424^39
+37 ;;^UTILITY(U,$J,358.3,48643,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,48643,1,3,0)
+40 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Bilateral,Unspec
+41 ;;^UTILITY(U,$J,358.3,48643,1,4,0)
+42 ;;=4^I69.965
+43 ;;^UTILITY(U,$J,358.3,48643,2)
+44 ;;=^5007566
+45 ;;^UTILITY(U,$J,358.3,48644,0)
+46 ;;=I69.962^^185^2424^40
+47 ;;^UTILITY(U,$J,358.3,48644,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,48644,1,3,0)
+50 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Dominant Side
+51 ;;^UTILITY(U,$J,358.3,48644,1,4,0)
+52 ;;=4^I69.962
+53 ;;^UTILITY(U,$J,358.3,48644,2)
+54 ;;=^5133588
+55 ;;^UTILITY(U,$J,358.3,48645,0)
+56 ;;=I69.964^^185^2424^41
+57 ;;^UTILITY(U,$J,358.3,48645,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,48645,1,3,0)
+60 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Nondominant Side
+61 ;;^UTILITY(U,$J,358.3,48645,1,4,0)
+62 ;;=4^I69.964
+63 ;;^UTILITY(U,$J,358.3,48645,2)
+64 ;;=^5133589
+65 ;;^UTILITY(U,$J,358.3,48646,0)
+66 ;;=I69.961^^185^2424^42
+67 ;;^UTILITY(U,$J,358.3,48646,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,48646,1,3,0)
+70 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Rt Dominant Side
+71 ;;^UTILITY(U,$J,358.3,48646,1,4,0)
+72 ;;=4^I69.961
+73 ;;^UTILITY(U,$J,358.3,48646,2)
+74 ;;=^5007564
+75 ;;^UTILITY(U,$J,358.3,48647,0)
+76 ;;=I69.963^^185^2424^43
+77 ;;^UTILITY(U,$J,358.3,48647,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,48647,1,3,0)
+80 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Rt Nondominant Side
+81 ;;^UTILITY(U,$J,358.3,48647,1,4,0)
+82 ;;=4^I69.963
+83 ;;^UTILITY(U,$J,358.3,48647,2)
+84 ;;=^5007565
+85 ;;^UTILITY(U,$J,358.3,48648,0)
+86 ;;=G90.50^^185^2424^52
+87 ;;^UTILITY(U,$J,358.3,48648,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,48648,1,3,0)
+90 ;;=3^Complex Regional Pain Syndrome I,Unspec
+91 ;;^UTILITY(U,$J,358.3,48648,1,4,0)
+92 ;;=4^G90.50
+93 ;;^UTILITY(U,$J,358.3,48648,2)
+94 ;;=^5004163
+95 ;;^UTILITY(U,$J,358.3,48649,0)
+96 ;;=R56.9^^185^2424^53
+97 ;;^UTILITY(U,$J,358.3,48649,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,48649,1,3,0)
+100 ;;=3^Convulsions,Unspec
+101 ;;^UTILITY(U,$J,358.3,48649,1,4,0)
+102 ;;=4^R56.9
+103 ;;^UTILITY(U,$J,358.3,48649,2)
+104 ;;=^5019524
+105 ;;^UTILITY(U,$J,358.3,48650,0)
+106 ;;=G37.9^^185^2424^54
+107 ;;^UTILITY(U,$J,358.3,48650,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,48650,1,3,0)
+110 ;;=3^Demyelinating Disease of Central Nervous System,Unspec
+111 ;;^UTILITY(U,$J,358.3,48650,1,4,0)
+112 ;;=4^G37.9
+113 ;;^UTILITY(U,$J,358.3,48650,2)
+114 ;;=^5003828
+115 ;;^UTILITY(U,$J,358.3,48651,0)
+116 ;;=G36.9^^185^2424^55
